Bodhi Tree Biotechnology Inc. (BDTB)

Every figure this model derived for BDTB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

The ratios

The figures themselves rather than their scores — what somebody looking up BDTB on one particular measure came for.

Everything else this filing tags

52 more elements from BDTB's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.

What to be careful about

What this model itself distrusts about BDTB's figures. Written by the derivation as it ran, not added afterwards.

• no current stock compensation tagged; treated as zero, so owner earnings are overstated
• no current capital expenditure tagged; treated as zero, so free cash flow is overstated and equals operating cash flow
• no usable diluted share count, so growth is measured on total revenue rather than per share; a company issuing shares to fund that growth reads better than it is
• there is no operating profit to value; valuation rests on EV/revenue (193.8x) instead
• no debt and no profit, so interest cover cannot be measured; scored on cash runway instead: 0M of net cash against a 0M annual burn is 0.0 years
• analyst estimate not used: trailing EPS is not positive, so a growth rate would be meaningless
• durability DROPPED from the total: only 0 of 4 inputs could be computed (worst year, contracted coverage, gross margin stability, cash flow stability not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
• resilience rests on 2 of 3 inputs; not tagged: liquidity
• growth rests on 3 of 4 inputs; not tagged: sustained growth